MedAvante-ProPhase

Dedicated to enabling smarter, faster #clinicaltrials.

[MedAvante-ProPhase @MedAvante]

#raredisease #rarediseaseday Webinar focusing on measurement issues in rare and orphan disorders, with a focus on neurodevelopment. Gahan Pandina and Abby Bangerter (Janssen) and Michael Aman (Ohio State University)expert presenters. https://t.co/BTuSyv80gg

[MedAvante-ProPhase @MedAvante]

Can the PANSS be modified to be useable in clinical settings as well as in research? https://t.co/SGoo4Ftiwa #Schizophrenia #ISCTM

[MedAvante-ProPhase @MedAvante]

@NIH says compound prevents neurological damage, shows cognitive benefits in mouse model of Alzheimer’s disease https://t.co/IEk5DQ0Djl

[MedAvante-ProPhase @MedAvante]

MedAvante-ProPhase Clinical Scientist Theresa Bromley, PhD is co-author of review article on prevention of passive and active misconduct in clinical trials. https://t.co/0yDFvAqlNV

[MedAvante-ProPhase @MedAvante]

Alzheimer Prevention Trials Web study: If you are at least 50 years of age and interested in #Alzheimers research, please join! https://t.co/u3kgslua3L

[MedAvante-ProPhase @MedAvante]

Remote patient monitoring fails to improve 6 clinical outcomes https://t.co/7SZ2Z2bmoz

[MedAvante-ProPhase @MedAvante]

DGM [deep grey matter] atrophy may be a useful outcome measure in neuroprotective clinical trials. https://t.co/7nKalq3wrT,

[MedAvante-ProPhase @MedAvante]

Pre-treatment Functioning Associated With Anxiolytic Efficacy of Vortioxetine https://t.co/7ntBQa2Qjd #GAD #Anxiety

[MedAvante-ProPhase @MedAvante]

WCG Announces — Strategies that Inform Investigation Selection and Enhance Enrollment,... https://t.co/xUpyN0GE6t via @benzinga

[Kate Zhong @KateZhongMD]

“We must overhaul our current recruitment strategies, to improve diversity & reach people who do not yet have symptoms” - Dr. Reisa Sperling of @BWH_MemoryStudy, one of 3 GAP-Net sites leading new $70 mil #Alzheimers #ClinicalTrial Consortium @harvardnews https://t.co/GJSvKwkRSl

[MedAvante-ProPhase @MedAvante]

Talk to the experts about the quality of your #Clinicaltrial data #eCOA

[EPAD @IMI_EPAD]

With the beginning of this new year, the @IMI_EPAD project is celebrating it’s 3rd birthday.
Wishing you all an exciting and happy New Year!
The #EPADistas

[Antidote @antidote_me]

When considering a trial, patients want to know details on what's being tested, and how much of their time the trial will take. Here's how you can share this information: https://t.co/9TzChSSNb2

[AD/PD - Advances in Science & Therapy @adpdnet]

FDA Approves Innovative #Parkinson’s Device Tested @UMNews - Vercise Deep Brain Stimulation (DBS) System https://t.co/pqO660G72D

[🟧 Hilary Evans-Newton 🟧 @HilaryAlzUK]

Huntington’s breakthrough may stop disease - this story is good news for all of us in dementia research! https://t.co/ueoCd1uZtf

[Avoca, A WCG Company @TheAvocaGroup]

WEBINAR TODAY AT 1 PM EST - It's not too late to sign-up and learn about @TheAvocaGroup's Clinical Quality Metrics Taxonomy. Register here - https://t.co/Is8PepOr3Q

[Edinburgh Dementia Prevention @CenDemPrevent]

Importance of communicating research into clinical practice - Prof Craig Ritchie emphasises @IMI_EPAD novel approach to developing new *preventative* dementia treatments #preventdementia2017

[MedAvante-ProPhase @MedAvante]

Wisconsin Researcher Seeks Veterans to Study Whether Fish Oil Delays Alzheimer’s Damage https://t.co/IvyFP1ybht

[American Society of Clinical Pschopharm (ASCP) @ASCPorg]

Attention residents, fellows, and trainees! Submit a travel fellowship nomination for the ASCP Annual Workshop on Clinical Trials in Psychopharmacology! The workshop is April 23-24, 2018 in NY. Visit https://t.co/sJVqzNr5Gq

[ScienceDaily @ScienceDaily]

Schizophrenia: How Can Avatar Therapy Help? https://t.co/5R1OYOZJWM